GlassScriptPhysician profile
Marc A Lavine
NPI 1801899281
$5,654.23
in general payments reported to CMS, 2019-2025
41 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $188 · 2021: $415 · 2022: $1,065 · 2023: $1,131 · 2024: $1,209 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,436 · Education: $5.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,435.89 |
| Education | $5.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $932.16 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $765.37 | 2019-2025 | Xtandi, Myrbetriq |
| Urovant Sciences INC | $381.32 | 2021-2022 | |
| Medtronic, INC. | $363.27 | 2023-2025 | Interstim, Concertotm |
| Janssen Biotech, INC. | $320.02 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $273.49 | 2021-2024 | Prolaris |
| Dentsply Ih Ab | $250.14 | 2023-2025 | Lofric, Lofric, Navina Rectal Catheter Set Regular |
| Abbvie INC. | $246.68 | 2019-2025 | |
| Convatec INC. | $212.42 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $191.75 | 2019-2025 | Adstiladrin |
| 180 Medical, INC. | $180.85 | 2019-2025 | |
| Urogen Pharma, INC. | $159.52 | 2023-2024 | Jelmyto |
| Mission Pharmacal Company | $139.92 | 2019-2024 | Uribel, Uribel Tabs |
| Bayer Healthcare Pharmaceuticals INC. | $137.10 | 2019-2025 | |
| Myovant Sciences INC. | $136.03 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Lavine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.